Company intelligence
IPS Therapeutique (IPST)
IPST is a CRO specializing in the preclinical evaluation of drug efficacy and safety using validated disease models.
About IPS Therapeutique (IPST)
IPS Therapeutique (IPST) is a Contract Research Organization (CRO) specializing in the preclinical evaluation of drug efficacy and safety using validated in vivo models. Since 1999, IPST has completed more than 3,000 cardiac studies and over 120 GLP programs supporting submissions to the FDA, EMA and Health Canada. Operating from a 36,000 sq.ft. facility in Sherbrooke (QC), the team designs customized studies and works closely with clients, with direct involvement from senior scientific leadership. Our expertise includes: - Cardiac models (HFpEF, HFrEF, cardiomyopathies, MI) - Vascular models (PAH, hemorrhagic shock, preeclampsia) - Inflammatory and fibrotic models (IPF, NASH, IBD) - Respiratory models (ARDS, COPD, chronic cough) - Coagulation models (thrombosis, thrombocytopenia, anticoagulant reversal)
Verified activity
Signals from IPS Therapeutique (IPST)
2 published signals
Presence & Recognition
IPS Therapeutique (IPST) is hosting the Director of in vivo pharmacology at the Inhalation Drug Delivery meeting in Parma.
Reported by IPS Therapeutique (IPST)
Research & Knowledge
IPS Therapeutique (IPST) designed in-vivo ARDS models to reproduce human disease features and support the evaluation of novel pharmacological interventions.
Reported by IPS Therapeutique (IPST)